
Optical components maker II-VI said on Tuesday it had received the Chinese market regulators’ antitrust clearance to buy laser maker Coherent, the final approval the US based-companies had been awaiting to close the deal.
With on-and-off trade tensions between Washington and Beijing, regulatory approval from China, which is an integral part of the supply chain, for acquisition deals have been in focus.
The Coherent deal had been under review of the State Administration for Market Regulation (SAMR) in China, which forced II-VI to delay the closing date. II-VI said it expects to close the deal by this week, around July 1.
Under II-VI’s offer terms made in March 2021, Coherent stockholders will receive $220 in cash and 0.91 II-VI shares, which valued Coherent at about $7 billion at the time.
Coherent supplies laser-based equipment used in making organic light-emitting diode (OLED) displays, which are becoming a popular choice for smartphones and high-end televisions due to their energy efficiency and better contrast and higher refresh rates.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas